Intrathecal herpes simplex virus type 1 amplicon vector-mediated human proenkephalin reduces chronic constriction injury-induced neuropathic pain in rats.

Wangyuan Zou,Qulian Guo,Chan Chen,Yong Yang,E Wang
DOI: https://doi.org/10.3892/mmr.2011.445
IF: 3.423
2011-01-01
Molecular Medicine Reports
Abstract:In the present study, we investigated the antinociceptive effect of herpes simplex virus type 1 (HSV-1) amplicon vector-mediated human proenkephalin (hPPE) on chronic constriction injury (CCI)-induced neuropathic pain in rats. Male Sprague-Dawley rats were intrathecally administered normal saline. (NS), pHSVIRES-lacZ (SHZ) or recombinant HSV-1 amplicon vector pHSVIRES-hPPE-lacZ (SHPZ), respectively. Once a week for 5 weeks after the intrathecal (it.) administration, the expression levels of hPPE mRNA and leu-enkephalin (L-EK) were determined. The paw withdrawal mechanical threshold (PWMT) and paw withdrawal thermal latency (PWTL) were measured before CCI (baseline) on day 3 and once a week for 5 weeks after it. administration. The results showed that the PWMT and PWTL in the SHPZ group were significantly increased compared to the thresholds before it. administration. The antinociceptive effect of SHPZ reached its peak 3 weeks after it. administration and was maintained for 5 weeks. In the rats administered vehicle or SHZ, there were no significant differences between the PWMT or PWTL and the thresholds before it. administration. These results indicate that a single i.t. administration of HSV-1 amplicon vector-mediated hPPE attenuated CO-induced hypersensitivity in rats.
What problem does this paper attempt to address?